Co ‐transplantation of haploidentical hematopoietic stem cell and allogeneic bone‐marrow‐derived mesenchymal stromal cells as a first‐line treatment in very severe aplastic anemia patients with refractory infections

ConclusionsUpfront HRD‐ HSCT may be a safe and promising choice for VSAA patients in critical situations without suitably matched donors.This article is protected by copyright. All rights reserved.

Source: European Journal of Haematology - March 13, 2018 Category: Hematology Authors: Chunyan Yue, Yingying Ding, Yang Gao, Li Li, Yan Pang, Zenghui Liu, Hang Zhang, Yang Xiao, Zujun Jiang, Haowen Xiao Tags: Original Article Source Type: research